PL312426A1 - Bicyclic tetrahydropyrazolepyridines - Google Patents

Bicyclic tetrahydropyrazolepyridines

Info

Publication number
PL312426A1
PL312426A1 PL94312426A PL31242694A PL312426A1 PL 312426 A1 PL312426 A1 PL 312426A1 PL 94312426 A PL94312426 A PL 94312426A PL 31242694 A PL31242694 A PL 31242694A PL 312426 A1 PL312426 A1 PL 312426A1
Authority
PL
Poland
Prior art keywords
tetrahydropyrazolepyridines
bicyclic
bicyclic tetrahydropyrazolepyridines
Prior art date
Application number
PL94312426A
Inventor
Allen Jacob Duplantier
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL312426A1 publication Critical patent/PL312426A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PL94312426A 1993-07-06 1994-06-16 Bicyclic tetrahydropyrazolepyridines PL312426A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8829293A 1993-07-06 1993-07-06
PCT/IB1994/000156 WO1995001980A1 (en) 1993-07-06 1994-06-16 Bicyclic tetrahydro pyrazolopyridines

Publications (1)

Publication Number Publication Date
PL312426A1 true PL312426A1 (en) 1996-04-29

Family

ID=22210524

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94312426A PL312426A1 (en) 1993-07-06 1994-06-16 Bicyclic tetrahydropyrazolepyridines

Country Status (20)

Country Link
EP (1) EP0707585A1 (en)
JP (1) JP2944048B2 (en)
KR (1) KR100228949B1 (en)
CN (1) CN1048015C (en)
AU (1) AU695301B2 (en)
BR (1) BR9406946A (en)
CA (1) CA2166721C (en)
CZ (1) CZ3696A3 (en)
EG (1) EG20513A (en)
FI (1) FI943208A (en)
HU (1) HUT74170A (en)
IL (1) IL110175A (en)
MX (1) MX9405132A (en)
NO (1) NO305029B1 (en)
NZ (1) NZ266525A (en)
PL (1) PL312426A1 (en)
RU (1) RU2131876C1 (en)
TW (1) TW316904B (en)
WO (1) WO1995001980A1 (en)
ZA (1) ZA944844B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT77517A (en) * 1994-10-20 1998-05-28 Pfizer Inc. Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
JP3107827B2 (en) * 1995-06-06 2000-11-13 ファイザー・インコーポレーテッド Tricyclic 5,6-dihydro-9H-pyrazolo [3,4-c] -1,2,4-triazolo [4,3-a] pyridines
AP932A (en) * 1996-08-26 2001-02-02 Pfizer Tricyclic 5,6-dihydro-9H-pyrazolo (3,4c)-1,2,4,-triazolo (4,3-a) pyridines.
KR100338610B1 (en) * 1996-09-04 2002-05-27 디. 제이. 우드, 스피겔 알렌 제이 Indazole Derivatives and Their Use as Inhibitors of Phosphodiesterase (PDE) type IV and the Production of Tumor Necrosis Factor (TNF)
US6858616B2 (en) 1998-12-23 2005-02-22 Bristol-Myers Squibb Pharma Company Nitrogen containing heterobicycles as factor Xa inhibitors
CN100340559C (en) 1998-12-23 2007-10-03 布里斯托尔-迈尔斯斯奎布药品公司 Nitrogen containing heterobicycles as factor XA inhibitors
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
SI1212089T1 (en) 1999-08-21 2006-08-31 Altana Pharma Ag Synergistic combination of roflumilast and salmeterol
TWI243055B (en) * 2000-04-13 2005-11-11 Nippon Zoki Pharmaceutical Co Pharmaceutical composition for use in treatment of dermatitis
EE05405B1 (en) * 2000-08-10 2011-04-15 Pharmacia Italia S.P.A. Bit clopazoles acting as kinase inhibitors, process for their preparation, use and pharmaceutical compositions containing them
US6960595B2 (en) * 2001-03-23 2005-11-01 Bristol-Myers Squibb Pharma Company 5-6 to 5-7 Heterobicycles as factor Xa inhibitors
WO2002085353A1 (en) 2001-04-18 2002-10-31 Bristol-Myers Squibb Company 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor xa inhibitors
CA2444571A1 (en) 2001-04-18 2002-10-31 Bristol-Myers Squibb Company 1, 4, 5, 6-tetrahydropyrazolo-¬3, 4-c|-pyridin-7-ones as factor xa inhi bitors
JP4196678B2 (en) 2001-04-26 2008-12-17 味の素株式会社 Heterocyclic compounds
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
KR101312736B1 (en) 2003-02-27 2013-09-27 팔라우 파르마 에스에이 Pyrazolopyridine derivates
US7135469B2 (en) * 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
EP1624893A2 (en) 2003-04-01 2006-02-15 Applied Research Systems ARS Holding N.V. Inhibitors of phosphodiesterases in infertility
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
DE102005031580A1 (en) * 2005-07-06 2007-01-11 Aicuris Gmbh & Co. Kg Substituted sulfolanylpyrazoles and their use
AR065804A1 (en) * 2007-03-23 2009-07-01 Smithkline Beecham Corp COMPOSITE OF INDOL CARBOXAMIDE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND USE OF THIS COMPOUND TO PREPARE A MEDICINAL PRODUCT
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN101772513B (en) 2007-06-04 2013-11-13 协同医药品公司 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2522968T3 (en) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (en) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer, and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828346C (en) 2011-03-01 2021-01-26 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
AU2014218599C1 (en) 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
JP2016514671A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists and uses thereof
WO2014197720A2 (en) 2013-06-05 2014-12-11 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase c, method of making and using same
NZ717739A (en) 2013-08-09 2023-12-22 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
CN110357888A (en) * 2018-04-09 2019-10-22 南京药捷安康生物科技有限公司 Heterocycle phosphodiesterase inhibitors and application thereof
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3365459A (en) * 1964-09-08 1968-01-23 Ciba Geigy Corp Certain tetrahydro pyrazolo-pyridine and pyrazolo-piperidine derivatives
FR1463883A (en) * 1964-09-08 1966-07-22 Ciba Geigy Process for the preparation of bicyclic triaza-compounds
US3340269A (en) * 1964-09-08 1967-09-05 Ciba Geigy Corp 1-substituted 4-acyl-2, 3-dioxo-piperidine
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines

Also Published As

Publication number Publication date
TW316904B (en) 1997-10-01
JPH08507084A (en) 1996-07-30
NZ266525A (en) 1997-10-24
CN1129940A (en) 1996-08-28
EG20513A (en) 1999-06-30
CN1048015C (en) 2000-01-05
AU695301B2 (en) 1998-08-13
WO1995001980A1 (en) 1995-01-19
KR960703852A (en) 1996-08-31
HU9503934D0 (en) 1996-03-28
CA2166721C (en) 1999-07-27
JP2944048B2 (en) 1999-08-30
ZA944844B (en) 1996-01-05
NO960056L (en) 1996-01-05
IL110175A (en) 2000-01-31
FI943208A (en) 1995-01-07
IL110175A0 (en) 1994-10-07
CZ3696A3 (en) 1997-06-11
AU6805794A (en) 1995-02-06
BR9406946A (en) 1996-08-06
KR100228949B1 (en) 1999-11-01
EP0707585A1 (en) 1996-04-24
NO960056D0 (en) 1996-01-05
NO305029B1 (en) 1999-03-22
HUT74170A (en) 1996-11-28
RU2131876C1 (en) 1999-06-20
MX9405132A (en) 1995-01-31
CA2166721A1 (en) 1995-01-19
FI943208A0 (en) 1994-07-05

Similar Documents

Publication Publication Date Title
PL312426A1 (en) Bicyclic tetrahydropyrazolepyridines
DE69433664D1 (en) Foetal-sensor
DE69400639D1 (en) Rehydratationsgetraenk
DE69426415D1 (en) Intrapulmonares hormonabgabesystem
DE69421914D1 (en) Ekg-sensor
DE69401926D1 (en) Hydroxamsäurederivate
HU9201781D0 (en) Bicyclic repamicines
DE69406448D1 (en) Luftreinigungsgerät
DE69405713D1 (en) Carbonylierungsverfahren
DE69412242D1 (en) Orthopädisches gussmaterial
DE59407177D1 (en) 2-fluorcycloyhexen-derivate
DE69423875D1 (en) Hydrodealkylierungsverfahren
DE59409705D1 (en) 3-methoxy-2-phenyl-acrylsäuremethylester
DE59408644D1 (en) Jacquardmaschine
DE69429512D1 (en) Thermoresistente alpha-1-antitrypsinmütante
DE69408437D1 (en) Oxychlorierungsverfahren
GB2274735B (en) Membraphone
EP0730584A4 (en) 3-acylaminobenzodiazepines
DE59408733D1 (en) Metallhalogenidentladungslampe
DE59410065D1 (en) 3-methoxy-2-phenyl-acrylsäuremethylester
DE69422299D1 (en) Photographisches reproduktionsgerät
DE69412128D1 (en) Kühlcontainer
GB2274048B (en) Headcollars
DE69407946D1 (en) Oxychlorierungskatalysator
DE69425743D1 (en) Faserreaktive anthrachinon-farbstoffe